Association between serum uric acid levels and cardiometabolic risk factors among japanese junior high school students

Circulation Journal

Volumn 74, Issue 8, 2010, Pages 1570-1577

  Hongo, Minoru ^a   Hidaka, Hiroya ^a   Sakaguchi, Shigeko ^a   Nakanishi, Keisuke ^a   Ichikawa, Motoki ^a   Hirota, Naoko ^b   Tanaka, Naoki ^c   Tsuruta, Goro ^c   Yazaki, Yoshikazu ^d   Kinoshita, Osamu ^e   Ikeda, Uichi ^c   Koike, Kenichi ^c  

^a SHINSHU UNIVERSITY   (Japan)

^b MATSUMOTO UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d National Hospital Organization Matsumoto Medical Center Matsumoto Hospital   (Japan)

^e Azumino Red Cross Hospital   (Japan)

Author keywords

Cardiometabolic risk factors; Japanese junior high school students; Lifestyle related diseases; Serum uric acid

Indexed keywords

GLUCOSE; URIC ACID;

ABDOMINAL OBESITY; ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; DYSLIPIDEMIA; EDUCATION PROGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HIGH SCHOOL STUDENT; HUMAN; HYPERTENSION; JAPANESE; LIFESTYLE; MALE; PREVALENCE; PREVENTIVE MEDICINE; REFERENCE VALUE; SCHOOL CHILD; SCHOOL HEALTH EDUCATION; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; DYSLIPIDEMIAS; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; MALE; METABOLIC DISEASES; OBESITY; RISK FACTORS; SEX FACTORS; STUDENTS; URIC ACID;

EID: 77955081160     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0837     Document Type: Article

References (46)

1. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am J Med 2005; 118: 816-826.
2. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
3. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-150.
4. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: The PIUMA study. Hypertension 2000; 36: 1072-1078.
5. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29: 635-639.
6. Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB. Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam Study. Stroke 2006; 37: 1503-1507.
7. Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, de Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65: 1041-1049.
8. Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, et al. Uric acid and left ventricular hypertrophy in Japanese men. Circ J 2009; 73: 667-672.
9. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemody-namic staging. Circulation 2003; 107: 1991-1997.
10. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003; 107: 1951-1953.
11. Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J 2006; 70: 1006-1011.
12. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med 2004; 164: 1546-1551.
13. Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: A longterm cohort study of atomic bomb survivors. J Rheumatol 2005; 32: 906-912.
14. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (The Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005; 96: 489-495.
15. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A Preventive Cardiology Information System (PreCIS) database cohort study. Arthritis Rheum 2008; 58: 623-630.
16. Okura T, Higaki J, Kurata M, Irita J, Miyoshi K, Yamazaki T, et al. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: Sub-analysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 2009; 73: 885-891.
17. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
18. Nagahama K, Iseki K, Touma T, Ikemiya Y, Takishita S. Hyper-uricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 227-233.
19. Ishizaka N, Ishizaka Y, Toda EI, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25: 1038-1044.
20. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120: 442-447.
21. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742.
22. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991; 266: 8604-8608.
23. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862.
24. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-252.
25. Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Chidhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 2005; 45: 34-38.
26. Jones DP, Richey PA, Alpert BS, Li R. Serum uric acid and ambulatory blood pressure in children with primary hypertension. Pediatr Res 2008; 64: 556-561.
27. Ford ES, Li C, Cook S, Choi HK. Serum concentration of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526-2532.
28. Pacifco L, Cantisani V, Anania C, Bonaiuto E, Martino F, Pascone R, et al. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endo-crinol 2009; 160: 45-52.
29. Azegami M, Hongo M, Yazaki Y, Yanagisawa S, Yamazaki A, Imamura H. Seasonal difference in onset of coronary heart disease in young patient: A comparison with older patients. Circ J 2005; 69: 1176-1179.
30. Azegami M, Hongo M, Yanagisawa S, Yamazaki A, Sakaguchi K, Yazaki Y, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: A comparison with older patients. Int Heart J 2006; 47: 343-350.
31. Tsuruta G, Tanaka N, Hongo M, Komatsu M, Horiuchi A, Hamamoto K, et al. Nonalcoholic fatty liver disease in Japanese junior high school students: Its prevalence and relationship to lifestyle habits. J Gastroenterol 2010 (in press).
32. Asayama K, Hayashibe H, Endo A, Okada T, Hara M, Masuda H, et al. Threshold value of visceral fat and waist girth in Japanese obese children. Pediatr Int 2005; 47: 498-504.
33. Matsuzawa Y. Metabolic syndrome: Defnition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.
34. Ozeki T, Satake E. Diagnostic criteria for metabolic syndrome and visceral adiposity in children. Adiposcience 2007; 4: 359-364 (in Japanese).
35. Japanese Society of Hypertension. Guidelines for the management of hypertension JSH2009, 2009; 83-86 (in Japanese).
36. Okada T, Murata M, Yamauchi K, Harada K. New criteria of normal serum lipid levels in Japanese children: The nationwide survey. Pediatr Int 2002; 44: 596-601.
37. Japanese Society of Gout and Nucleic Acid Metabolism. Guideline for the management of hyperuricemia and gout, 2nd edition. Osaka: Medical Review Co, 2010 (in Japanese).
38. Biggerstaff BJ. Comparing diagnostic tests: A simple graphic using likelihood ratios. Stat Med 2000; 19: 649-663.
39. Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, et al. Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med 2006; 209: 257-262.
40. Caprio S, Hyman LD, McCarthy S, Lange R, Bronson M. Fat distribution and cardiovascular risk factors in obese adolescent girls: Importance of the intraabdominal fat depot. Am J Clin Nutr 1996; 64: 12-17.
41. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tatò L. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res 2001; 9: 179-187.
42. Lee S, Bacha F, Gungor N, Arslanian SA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr 2006; 148: 188-194.
43. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631.
44. Ding K, Kullo IJ. Genome-wide association studies for atherosclerotic vascular disease and its risk factors. Circ Cardiovasc Genet 2009; 2: 63-72.
45. de Ferranti SD, Osganian SK. Epidemiology of pediatric metabolic syndrome and type 2 diabetes mellitus. Diabetes Vasc Dis Res 2007; 4: 285-296.
46. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, et al. Progress and challenges in metabolic syndrome in children and adolescents. Circulation 2009; 119: 628-647.